SLT lasers do not infringe Trimedyne's '737 patent, district court rules.
This article was originally published in The Gray Sheet
Executive Summary
SLT CONTACT LASER PRODUCTS DO NOT INFRINGE TRIMEDYNE PATENT covering laser probes for thermal tissue ablation, the U.S. District Court for the Central District of California ruled Nov. 8. The court granted Surgical Laser Technologies' motion for summary judgment that its contact laser products do not infringe Trimedyne's patent No. 4,646,737.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.